Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy

[1] Okamoto K(2004)The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition Proc Natl Acad Sci U S A 101 7931-7936

[2] Matsumoto K(2002)The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction Microcirculation. 9 161-175

[3] Hille R(2010)Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function J Am Coll Surg 211 587-595

[4] Eger BT(1995)Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase FASEB J 9 995-1003

[5] Pai EF(2003)Xanthine oxidoreductase is central to the evolution and function of the innate immune system Trends Immunol 24 512-517

[6] Nishino T(1979)Intermediate dehydrogenase-oxidase form of xanthine oxidoreductase in rat liver Biochem J 181 177-182

[7] Meneshian A(2014)Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme Biochim Biophys Acta 1842 1502-1517

[8] Bulkley GB(2009)Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules Hypertension. 54 868-876

[9] Dolegowska B(2020)The Effects of Platelet-Rich and Platelet-Poor Plasma on Biological Characteristics of BM-MSCs In Vitro Anal Cell Pathol (Amst) 26 8546231-1177

[10] Blogowski W(2013)Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology Ther Deliv 4 1163-567

[1] Okamoto K(2004)The crystal structure of xanthine oxidoreductase during catalysis: implications for reaction mechanism and enzyme inhibition Proc Natl Acad Sci U S A 101 7931-7936

[2] Matsumoto K(2002)The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction Microcirculation. 9 161-175

[3] Hille R(2010)Clinical evidence of the association between serum perioperative changes in xanthine metabolizing enzymes activity and early post-transplant kidney allograft function J Am Coll Surg 211 587-595

[4] Eger BT(1995)Flavoprotein structure and mechanism. 4. Xanthine oxidase and xanthine dehydrogenase FASEB J 9 995-1003

[5] Pai EF(2003)Xanthine oxidoreductase is central to the evolution and function of the innate immune system Trends Immunol 24 512-517

[6] Nishino T(1979)Intermediate dehydrogenase-oxidase form of xanthine oxidoreductase in rat liver Biochem J 181 177-182

[7] Meneshian A(2014)Pathophysiology of circulating xanthine oxidoreductase: new emerging roles for a multi-tasking enzyme Biochim Biophys Acta 1842 1502-1517

[8] Bulkley GB(2009)Xanthine oxidoreductase depletion induces renal interstitial fibrosis through aberrant lipid and purine accumulation in renal tubules Hypertension. 54 868-876

[9] Dolegowska B(2020)The Effects of Platelet-Rich and Platelet-Poor Plasma on Biological Characteristics of BM-MSCs In Vitro Anal Cell Pathol (Amst) 26 8546231-1177

[10] Blogowski W(2013)Safety and efficient ex vivo expansion of stem cells using platelet-rich plasma technology Ther Deliv 4 1163-567